Page 16 - hypertension_newsletter7

REFLECTIONS
Hypertension
Hypertension Global Newsletter #7 2024

Individualising selection of antiobesity medications among
specific populations with obesity common in primary care settings Hypertension

All AOMs are approved as adjunctive therapy to a reduced-
calorie diet and increased physical activity. The authors note
that clinicians should continue to counsel patients on these
lifestyle modifications at the time of AOM initiation. AOMs
are effective adjunctive therapies to lifestyle changes for
improved weight loss and health outcomes, notably because
obesity is associated with multiple comorbidities such as
hypertension.

CLICK HERE
TO LISTEN TO A PODCAST BY ONE
OF THE AUTHORS, DR. KUSHNER,
WHERE HE DISCUSSES OBESITY
MEDICATIONS, AND HOW THEY
IMPROVE HEALTH OUTCOMES AND
MINIMISE ADVERSE EFFECTS IN CLICK HERE
PEOPLE WITH OBESITY. FOR THE LINK TO FULL ARTICLE

TABLE OF CONTENTS